Jørn Herrstedt
Medlem af:
Klinisk onkologi
1 - 1 ud af 1Pr. side: 10
- Udgivet
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Herrstedt, Jørn, Apornwirat, W., Shaharyar, A., Aziz, Z., Roila, F., Van Belle, S., Russo, M. W., Levin, J., Ranganathan, S., Guckert, M. & Grunberg, S. M., 2009, I: Journal of Clinical Oncology. 27, 32, s. 5363-9 7 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
ID: 182566628
Flest downloads
-
55
downloads
Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
44
downloads
Similarities and Differences between Danish and American Physicians' Religious Characteristics and Clinical Communication: Two Cross-Sectional Surveys
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
32
downloads
High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet